. 2017 Sep 14;9(3):505–511. doi: 10.1111/jdi.12720

Table 3.

Relationships between tissue fat content and clinical or oral glucose tolerance test‐based parameters

	PFC		HFC		IMCL		VF		SCF
	r	P	r	P	r	P	r	P	r	P
Age	0.590	0.001	0.399	0.029	0.014	0.941	0.613	<0.001	0.030	0.873
BMI	0.501	0.005	0.527	0.003	0.191	0.311	0.606	<0.001	0.549	0.002
Sex	−0.392	0.032	−0.579	0.001	0.026	0.892	−0.484	0.007	0.037	0.846
FPG	0.489	0.006	0.466	0.009	−0.036	0.850	0.298	0.110	−0.017	0.929
F‐IRI	0.520	0.003	0.361	0.050	0.050	0.792	0.481	0.007	0.223	0.237
Serum TG	0.439	0.015	0.345	0.062	−0.066	0.730	0.523	0.003	0.204	0.279
Serum FFAs	−0.036	0.849	−0.076	0.690	0.153	0.419	−0.085	0.654	−0.106	0.578
HOMA‐β	0.074	0.696	0.076	0.690	0.073	0.700	0.231	0.220	0.167	0.378
Insulinogenic index	0.145	0.446	−0.123	0.517	−0.192	0.308	0.037	0.845	0.068	0.721
AUC_ins120	0.332	0.073	0.342	0.064	0.033	0.862	0.337	0.068	0.396	0.030
AUC_ins/glu120	0.203	0.282	0.173	0.360	0.036	0.850	0.200	0.290	0.397	0.030
HOMA‐IR	0.619	<0.001	0.483	0.007	0.034	0.858	0.558	0.001	0.282	0.131
Composite index	−0.433	0.017	−0.416	0.022	−0.059	0.755	−0.388	0.034	−0.197	0.296
Oral DI	−0.403	0.027	−0.435	0.016	0.018	0.925	−0.347	0.060	0.184	0.330

AUC_glu120, area under the glucose concentration curve; AUC_ins120, area under the insulin concentration curve; BMI, body mass index; DI, disposition index; FFAs, free fatty acids; F‐IRI, fasting serum insulin concentration; FPG, fasting plasma glucose concentration; HFC, hepatic fat content; HOMA‐β, homeostasis model assessment of β‐cell function; HOMA‐IR, homeostasis model assessment of insulin resistance; IMCL, intramyocellular lipid content; PFC, pancreatic fat content; SCF, subcutaneous fat area; TG, triglyceride; VF, visceral fat area.